RXDX - Prometheus Biosciences Inc
Close
199.93
174.640 87.351%
Share volume: 0
Last Updated: Thu 15 Jun 2023 08:10:52 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$25.29
174.64
690.55%
Summary score
57%
Profitability
68%
Dept financing
0%
Liquidity
0%
Performance
75%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RXDX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 29.06% |
| Return on assets | 0% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 0% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 0% | 50% |
| Total debt ratio | 0% | 0% | 0% | 183.15% |
| Debt ratio change over time | 0% | 0% | 0% | 19.02% |
| Dept financing | 0% | 0% | 0% | 50% |
| Current Ratio | 0% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0% | 0% | 0% | 5.68% |
| Liquididy | 0% | 0% | 0% | 75% |
| Short-term ratios | RXDX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -16.12% |
| Return on assets | 0% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 0% | 0% | 0% | 96.56% |
| Profitability | 75% | 0% | 0% | 25% |
| Total debt ratio | 0% | 0% | 0% | 79.61% |
| Debt ratio change over time | 0% | 0% | 0% | 0.09% |
| Dept financing | 0% | 0% | 0% | 50% |
| Current Ratio | 0% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0% | 0% | 0% | 5.68% |
| Liquididy | 0% | 0% | 0% | 75% |